Marked sweating of the hands and feet is one of the common localized forms of hyperhidrosis that can affect daily life. Botulinum toxin, also commonly referred to as “hand sweating Botox,” temporarily reduces the nerve signals that stimulate the sweat glands. This procedure may be used to help control localized sweating. The decision to perform the procedure should be made by a physician after evaluating the cause of the sweating and the individual’s medical characteristics.
In general, botulinum toxin for excessive sweating reduces sweat production by temporarily blocking the effects of acetylcholine released from the nerves that stimulate the sweat glands. The injections are administered into the superficial layers of the skin, temporarily suppressing the activity of the sweat glands in the target area. This does not stop sweating throughout the entire body; it reduces excessive sweating only in the treated area. For example, it may be applied specifically to the feet for the management of excessive foot sweating.
This method may be considered particularly in primary focal hyperhidrosis, which refers to excessive sweating that occurs in specific areas and cannot be explained by another underlying condition. Since sweating is necessary for regulating body temperature, the aim is not to eliminate physiological sweating completely, but to reduce excessive sweat production in the affected area.
Depending on the clinical assessment, botulinum toxin may be applied to the palms of the hands and the soles of the feet. Because of the anatomical characteristics of these areas, appropriate technical planning is important.
In individuals whose excessive sweating is concentrated in the palms, botulinum toxin may be used to reduce localized sweat production. The procedure may be performed on both hands, and it may also be considered for patients who experience excessive sweating of the feet.
Botulinum toxin for foot sweating may be considered particularly in individuals with pronounced sweating of the soles. Injections into the soles of the feet may be more painful than injections into the palms, and the effectiveness of the procedure may vary from person to person. The physician evaluates the impact of sweating on footwear use, skin moisture, and daily activities, and the procedure may be considered for suitable individuals.
Botulinum toxin treatment for excessive sweating of the hands and feet may be considered by a physician in individuals with one or more of the following characteristics:
Sweating is predominantly concentrated in the palms or soles.
Sweating has persisted for a long time and affects daily life.
Primary focal hyperhidrosis is suspected.
Antiperspirants or similar conservative options have not provided sufficient benefit.
Alternatives such as iontophoresis are not suitable or do not provide adequate control.
Sweating causes noticeable difficulty with writing, shaking hands, working, wearing shoes, or participating in social activities.
The individual’s medical history, current medications, and the condition of the treatment area are considered suitable for botulinum toxin treatment for excessive sweating.
For children or adolescents, the decision should be made separately by a physician, taking into account age, clinical condition, and other available options.
The purpose of the initial assessment is to determine the type of excessive sweating, rule out secondary causes, and evaluate suitability for botulinum toxin treatment. Several factors therefore need to be assessed before determining whether the individual may be an appropriate candidate for hyperhidrosis treatment.
| Assessment | What Is Evaluated? | Why Is It Important? |
|---|---|---|
| Sweating history | Age at onset, duration, triggers, and distribution | Helps distinguish focal from generalized sweating |
| Medical history | Medical conditions, previous treatments, and procedures | Helps determine the appropriate treatment option |
| Medications | Regularly used medications and supplements | Some medications may affect the effects of botulinum toxin |
| Examination | Condition of the skin on the hands and feet, including infection or irritation | Helps determine whether the injection area is suitable |
| Differential assessment | Medical conditions that may cause excessive sweating | Helps avoid overlooking secondary hyperhidrosis |
| Previous treatments | Response to antiperspirants, iontophoresis, and other options | Contributes to determining the treatment sequence |
| Suitability assessment | Conditions such as pregnancy, breastfeeding, and neuromuscular disorders | Helps identify situations that may involve additional risk |
The procedure may not be appropriate in certain situations, including infection at the injection site, some neuromuscular disorders, pregnancy, and breastfeeding. It is also important to inform the physician about all medications being used. Any medications that were recently discontinued should also be reported.
The procedure is performed by identifying the target area, selecting an appropriate anesthesia method, and administering multiple small injections into the skin. For the hands, regional nerve blocks, cooling, or vibration may be used when necessary to reduce discomfort during the procedure. An appropriate anesthesia approach may also be planned for pain control when treating the soles of the feet.
The number, dosage, and location of the injections vary depending on the individual’s anatomy, the extent of the sweating area, and the preparation used. For this reason, it would not be appropriate to provide a fixed number of injections or a standard dose that applies to everyone. After the procedure, the follow-up plan recommended by the physician should be followed.
The effect of botulinum toxin for excessive sweating usually begins to become noticeable within a few days, while the full effect may take up to approximately two weeks to become apparent. However, the onset of the effect may vary depending on the product used, the treatment area, and individual characteristics.
The effect of botulinum toxin for excessive sweating lasts for several months in many individuals, and an average duration of approximately 6–7 months has been reported for palmar applications. In some individuals, the effect may last for a longer or shorter period. As the effect gradually decreases, sweating may return over time. Whether the procedure should be repeated is determined through clinical assessment.
Most side effects associated with botulinum toxin treatment for excessive sweating are temporary. However, their type and duration may vary depending on the injection area and individual characteristics.
| Frequency | Possible Side Effect | Approximate Duration | Additional Information |
|---|---|---|---|
| Common | Pain, tenderness, redness, bruising | Usually a few days | Local findings related to the injections |
| Common | Discomfort during the procedure | During the procedure | May be more noticeable in the palms and soles |
| Uncommon | Temporary weakness of the hand muscles | Days to weeks | May be associated with spread to nearby muscles in palmar applications |
| Uncommon | Numbness or tingling | Usually short-term | May be related to local injections or anesthesia |
| Uncommon | Insufficient reduction in sweating or early recurrence | Variable | Related to individual response and the treatment area |
| Very rare | Systemic effects such as generalized muscle weakness | Variable | Prompt medical evaluation is required if symptoms become widespread |
| Very rare | Serious allergic reaction | Acute | Urgent medical evaluation is required if difficulty breathing or generalized swelling develops |
Temporary muscle weakness following injections into the palms is an effect that individuals considering the procedure should be aware of. Clinical studies have reported that changes in the electrical activity of some hand muscles are temporary and may return to normal over time. Although the effect of botulinum toxin is localized, inappropriate dosage or technique may increase risks, making it important for the procedure to be performed by a physician.
Certain medications may also affect the action of botulinum toxin or the risk of muscle weakness. For this reason, prescription medications, over-the-counter products, and supplements should be discussed with the physician before the procedure. If unusual or progressively worsening symptoms develop after botulinum toxin treatment for hyperhidrosis, the individual should contact a healthcare facility.
How long does the effect of botulinum toxin for excessive sweating last?
The effect generally lasts for several months; an average duration of approximately six to seven months has been reported for the palms.
Is the effect of botulinum toxin for excessive sweating permanent?
No. The effect of botulinum toxin on sweating is temporary and gradually decreases over time.
When does the effect of botulinum toxin for excessive sweating begin?
Initial changes may begin within a few days, while the full effect may become more noticeable after approximately two weeks.
Is botulinum toxin treatment for hand and foot sweating painful?
The injections may cause discomfort. Anesthesia methods may be used for pain control, particularly for treatments involving the palms and soles.
Are there side effects of botulinum toxin treatment for excessive sweating?
Yes. Pain, tenderness, and bruising may occur, and temporary muscle weakness may also develop after palmar applications.
Can botulinum toxin treatment for excessive sweating also reduce body odor?
Sweat itself is generally not strongly odorous. Because odor may develop through the interaction between microorganisms on the skin and components of sweat, reducing sweating may indirectly reduce odor in some individuals.
Can botulinum toxin treatment for excessive sweating be performed on everyone?
No. Pregnancy, breastfeeding, certain neuromuscular disorders, infection at the injection site, and the use of certain medications may be contraindications or reasons for additional assessment.
This content is intended for general health information only and does not replace diagnosis or individualized treatment advice. Personal risks and expectations should be assessed separately by a physician.